findmyKOL
Clinical trialNCT02619877CompletedPhase 2Interventional

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers

SponsorAnterogen Co., Ltd.Enrollment59Diabetic Foot Ulcer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Korea University Guro Hospital

    Guro-gu, Seoul, South Korea

  • Eulji General Hospital

    Nowon-Gu, Seoul, South Korea

  • Severance Hospital

    Seodaemun-Gu, Seoul, South Korea

  • Asan Medical Center

    Songpa-Gu, Seoul, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2015
Primary completion
30 Sept 2016
Completion
31 Oct 2016
Last update posted
1 Sept 2017
Registered enrollment
59
Registry id
NCT02619877

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.